The following commentary comes from an independent investor or market observer as part of TheStreet's guest contributor program, which is separate from the company's news coverage.NEW YORK ( Trefis) --
Cramer says Bluebird Bio is too speculative for him but he likes Enterprise Products Partners.
The market is fearful. Use that fear to buy, Cramer says.
Here's a technical look at how to trade some of the most active stocks on the market right now.